These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 7681656)

  • 1. Biologic effects after a single dose of poly(I):poly(C12U) in healthy volunteers.
    Hendrix CW; Margolick JB; Petty BG; Markham RB; Nerhood L; Farzadegan H; Ts'o PO; Lietman PS
    Antimicrob Agents Chemother; 1993 Mar; 37(3):429-35. PubMed ID: 7681656
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mode of action of the anti-AIDS compound poly(I).poly(C12U) (Ampligen): activator of 2',5'-oligoadenylate synthetase and double-stranded RNA-dependent kinase.
    Ushijima H; Rytik PG; Schäcke H; Scheffer U; Müller WE; Schröder HC
    J Interferon Res; 1993 Apr; 13(2):161-71. PubMed ID: 8099601
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Changes in the 2-5A synthetase/RNase L antiviral pathway in a controlled clinical trial with poly(I)-poly(C12U) in chronic fatigue syndrome.
    Suhadolnik RJ; Reichenbach NL; Hitzges P; Adelson ME; Peterson DL; Cheney P; Salvato P; Thompson C; Loveless M; Müller WE
    In Vivo; 1994; 8(4):599-604. PubMed ID: 7893988
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 8-Azido double-stranded RNA photoaffinity probes. Enzymatic synthesis, characterization, and biological properties of poly(I,8-azidoI).poly(C) and poly(I,8-azidoI).poly(C12U) with 2',5'-oligoadenylate synthetase and protein kinase.
    Li SW; Moskow JJ; Suhadolnik RJ
    J Biol Chem; 1990 Apr; 265(10):5470-4. PubMed ID: 2318823
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effects of poly(I).poly(C12U) and interferon on the multiplication of a mammalian type C retrovirus in human cells.
    Chelbi-Alix MK; Belforte B; Saal F; Lasneret J; Peries J; Thang MN
    J Gen Virol; 1992 Sep; 73 ( Pt 9)():2291-7. PubMed ID: 1383406
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of DNA topoisomerase I activity by 2',5'-oligoadenylates and mismatched double-stranded RNA in uninfected and HIV-1-infected H9 cells.
    Schröder HC; Kelve M; Schäcke H; Pfleiderer W; Charubala R; Suhadolnik RJ; Müller WE
    Chem Biol Interact; 1994 Feb; 90(2):169-83. PubMed ID: 8156606
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human biologic response modification by interferon in the absence of measurable serum concentrations: a comparative trial of subcutaneous and intravenous interferon-beta serine.
    Goldstein D; Sielaff KM; Storer BE; Brown RR; Datta SP; Witt PL; Teitelbaum AP; Smalley RV; Borden EC
    J Natl Cancer Inst; 1989 Jul; 81(14):1061-8. PubMed ID: 2472488
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dose-related effects of Ampligen (poly(I).poly(C12U)), a mismatched double-stranded RNA, in a bleomycin-mouse model of pulmonary fibrosis.
    Wild JS; Hyde DM; Hubbell HR; Giri SN
    Exp Lung Res; 1996; 22(3):375-91. PubMed ID: 8792127
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The dynamics of 2',5'-oligoadenylate synthetase activity in the nuclear and cytoplasmic fractions of human fibroblasts treated by double-stranded RNAs, by their complexes with DEAE-dextran and by type-I recombinant interferons. The ratio of double-stranded RNA-activated and -nonactivated froms of the enzyme].
    Sokolova TM; Antonov AIu; Makhov AM
    Antibiot Khimioter; 1991 Jun; 36(6):31-5. PubMed ID: 1898186
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mismatched double-stranded RNA, Ampligen (poly(I): poly(C12U), demonstrates antiviral and immunostimulatory activities in HIV disease.
    Carter WA; Ventura D; Shapiro DE; Strayer DR; Gillespie DH; Hubbell HR
    Int J Immunopharmacol; 1991; 13 Suppl 1():69-76. PubMed ID: 1688087
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A misaligned double-stranded RNA, poly(I).poly(C12,U), induces accumulation of 2',5'-oligoadenylates in mouse tissues.
    Hearl WG; Johnston MI
    Biochem Biophys Res Commun; 1986 Jul; 138(1):40-6. PubMed ID: 2427076
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synergistic inhibition of AZT-resistant HIV by AZT combined with poly(I):poly(C12U), without synergistic toxicity to bone marrow progenitor cell elements.
    Gillespie D; Hubbell HR; Carter WA; Midgette P; Elsasser W; Mullaney R; Strayer DR
    In Vivo; 1994; 8(3):375-81. PubMed ID: 7803722
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Upregulation of the 2-5A synthetase/RNase L antiviral pathway associated with chronic fatigue syndrome.
    Suhadolnik RJ; Reichenbach NL; Hitzges P; Sobol RW; Peterson DL; Henry B; Ablashi DV; Müller WE; Schröder HC; Carter WA
    Clin Infect Dis; 1994 Jan; 18 Suppl 1():S96-104. PubMed ID: 8148461
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A controlled clinical trial with a specifically configured RNA drug, poly(I).poly(C12U), in chronic fatigue syndrome.
    Strayer DR; Carter WA; Brodsky I; Cheney P; Peterson D; Salvato P; Thompson C; Loveless M; Shapiro DE; Elsasser W
    Clin Infect Dis; 1994 Jan; 18 Suppl 1():S88-95. PubMed ID: 8148460
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of fibroblast and recombinant leukocyte interferons and double-stranded RNA on ppp(2'-5')An synthesis and cell proliferation in human colon carcinoma cells in vitro.
    Chapekar MS; Glazer RI
    Cancer Res; 1983 Jun; 43(6):2683-7. PubMed ID: 6189584
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Production of interferon-alpha induced by dsRNA in human peripheral blood mononuclear cell cultures: role of priming by dsRNA-induced interferons-gamma and -beta.
    Lepe-Zuniga JL; Rotbein J; Gutterman JU
    J Interferon Res; 1989 Aug; 9(4):445-56. PubMed ID: 2502585
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vivo antiviral effects of mismatched double-stranded RNA on duck hepatitis B virus.
    Ijichi K; Mitamura K; Ida S; Machida H; Shimada K
    J Med Virol; 1994 Jun; 43(2):161-5. PubMed ID: 8083664
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biological and clinical effects of the combination of beta- and gamma-interferons administered as a 5-day continuous infusion.
    Schiller JH; Storer B; Witt PL; Nelson B; Brown RR; Horisberger M; Grossberg S; Borden EC
    Cancer Res; 1990 Aug; 50(15):4588-94. PubMed ID: 2114942
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel controlled-release Lemna-derived IFN-alpha2b (Locteron): pharmacokinetics, pharmacodynamics, and tolerability in a phase I clinical trial.
    De Leede LG; Humphries JE; Bechet AC; Van Hoogdalem EJ; Verrijk R; Spencer DG
    J Interferon Cytokine Res; 2008 Feb; 28(2):113-22. PubMed ID: 18279106
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pilot study of natural human interleukin-2 in patients with chronic hepatitis B. Immunomodulatory and antiviral effects.
    Tilg H; Vogel W; Tratkiewicz J; Aulitzky WE; Herold M; Gruber M; Geissler D; Umlauft F; Judmaier G; Schwulera U
    J Hepatol; 1993 Sep; 19(2):259-67. PubMed ID: 8301059
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.